17.11.2014 - French specialty vaccine developer Abivax has appointed Karl Birthistle as Vice President Global Regulatory Affairs. At the same time, his colleague Daniel Kenny was named Chief Commercial Officer & VP of Business Development at the firm.
A physician by trade, Birthistle moved sideways into the pharma and biotech industries, where he has held positions focussing on drug, biologics and vaccines development, working at British SmithKlineBeecham, Dutch Pharming, Austrian Baxter BioScience and other firms. His most recent post was as Director of Clinical Development and Safety Assessments for Philip Morris in Switzerland. Birthistle remains Deputy Head of the Clinical Review Division of Swissmedic, the Swiss regulatory authority.http://www.european-biotechnology-news.com/people/bio-people/2014/karl-birthistle.html